ASEP Medical Holdings Inc. (CSE:ASEP)
Canada · Delayed Price · Currency is CAD 0.1300
0.00 (0.00%)
Sep 18, 2026, 11:18 AM EST
ASEP Medical Holdings Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.34 | 0.34 | 0.3 | 0.02 | - | - | |
Revenue Growth | 13.48% | 13.17% | 1307.69% | - | - | - |
Gross Profit | 0.34 | 0.34 | 0.3 | 0.02 | - | - |
Selling, General & Admin | 1.62 | 1.91 | 2.15 | 2.71 | 1.58 | 0.79 |
Research & Development | 0.12 | 0.1 | 0.08 | 0.68 | 0.62 | 0.08 |
Amortization of Goodwill & Intangibles | 0.58 | 0.71 | 1.3 | 1.29 | 1.28 | 0.19 |
Operating Expenses | 2.32 | 2.72 | 3.96 | 6.63 | 4.6 | 2.11 |
Operating Income | -1.98 | -2.38 | -3.66 | -6.61 | -4.6 | -2.11 |
Interest Expense | -0.04 | -0.03 | -0 | -0 | -0 | -0.11 |
Interest & Investment Income | 0.01 | 0 | - | - | - | - |
Earnings From Equity Investments | - | - | -0.18 | - | - | - |
Currency Exchange Gain (Loss) | 0 | 0.01 | -0.01 | -0 | -0 | -0 |
Other Non Operating Income (Expenses) | -0.16 | -0.18 | -0.23 | -1.11 | -0.85 | -0.34 |
EBT Excluding Unusual Items | -2.17 | -2.58 | -4.09 | -7.73 | -5.45 | -2.56 |
Merger & Restructuring Charges | - | - | - | -1.28 | -0.4 | - |
Gain (Loss) on Sale of Investments | 0.14 | -0.04 | 0.27 | - | - | - |
Asset Writedown | -4.39 | -4.39 | -9.88 | - | - | - |
Other Unusual Items | -0.19 | -0.43 | - | -0.43 | - | - |
Pretax Income | -6.61 | -7.44 | -13.7 | -9.43 | -5.85 | -2.56 |
Income Tax Expense | -0.05 | - | - | - | -0.09 | - |
Earnings From Continuing Operations | -6.56 | -7.44 | -13.7 | -9.43 | -5.76 | -2.56 |
Minority Interest in Earnings | 2.44 | 2.53 | 5.43 | 1.2 | 1.23 | 0.16 |
Net Income | -4.12 | -4.92 | -8.27 | -8.23 | -4.52 | -2.4 |
Net Income to Common | -4.12 | -4.92 | -8.27 | -8.23 | -4.52 | -2.4 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 12 | 10 | 8 | 6 | 6 | 2 |
Shares Outstanding (Diluted) | 12 | 10 | 8 | 6 | 6 | 2 |
Shares Change | 40.29% | 35.48% | 22.16% | 10.75% | 163.12% | 967.89% |
EPS (Basic) | -0.34 | -0.48 | -1.09 | -1.32 | -0.81 | -1.12 |
EPS (Diluted) | -0.34 | -0.48 | -1.09 | -1.32 | -0.81 | -1.12 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.23 | -1.02 | -0.34 | -2.71 | -3.61 | -1.37 |
Free Cash Flow Per Share | -0.10 | -0.10 | -0.04 | -0.44 | -0.64 | -0.64 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | - | - |
Operating Margin | -587.47% | -707.64% | -1229.41% | -31271.78% | - | - |
Profit Margin | -1223.05% | -1459.70% | -2779.83% | -38918.30% | - | - |
Free Cash Flow Margin | -366.18% | -302.24% | -113.29% | -12837.39% | - | - |
EBITDA | -1.4 | -1.67 | -2.37 | -5.33 | -3.33 | -1.92 |
D&A For EBITDA | 0.58 | 0.71 | 1.29 | 1.28 | 1.27 | 0.19 |
EBIT | -1.98 | -2.38 | -3.66 | -6.61 | -4.6 | -2.11 |
Revenue as Reported | 0.34 | 0.34 | 0.3 | 0.02 | - | - |